{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:31:06Z","timestamp":1791088266447,"version":"4.1.0"},"reference-count":36,"publisher":"Japan Atherosclerosis Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2004]]},"DOI":"10.5551\/jat.11.131","type":"journal-article","created":{"date-parts":[[2011,6,16]],"date-time":"2011-06-16T13:45:32Z","timestamp":1308231932000},"page":"131-145","source":"Crossref","is-referenced-by-count":35,"title":["Mutations in Japanese Subjects with Primary Hyperlipidemia<BR>— Results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996 —"],"prefix":"10.5551","volume":"11","author":[{"given":"Takao","family":"Maruyama","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Matsuzawa","sequence":"additional","affiliation":[{"name":"Sumitomo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Bujo","sequence":"additional","affiliation":[{"name":"Department of Genome Research and Clinical Application, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Saito","sequence":"additional","affiliation":[{"name":"Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Jichi Medical School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Faculty of Medicine, University of Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Futoshi","family":"Shionoiri","sequence":"additional","affiliation":[{"name":"Yokosuka Hokubu Kyosai Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanari","family":"Gotoda","sequence":"additional","affiliation":[{"name":"Diabetes Center, Tokyo Women’s Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Yamada","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","unstructured":"(1) Goldstein JL, Hobbs HH, and Brown MS: Familial hypercholesterolemia. In: The metabolic and molecular bases of inherited disease. 8th Ed, ed by Scriver CR, Beaudet Al, Sly WS, and Valle D, pp 2863−2913, McGraw-Hill, New York, 2001"},{"key":"2","unstructured":"(2) Ishibashi S: Clinical characteristics and mutational analysis in Japanese patients with primary hyperlipidemia. In: Annual report of Research Committee on Primary Hyperlipidemia (Ministry of Health and Welfare of Japan), pp 47−51, 1998 (in Japanese)"},{"key":"3","doi-asserted-by":"crossref","unstructured":"(3) Maruyama T, Miyake Y, Tajima S, Harada-shiba M, Yamamura T, Tsushima M, Kishino B, Horiguchi Y, Funahashi T, Matsuzawa Y, and Yamamoto A: Common mutations in the low-density-lipoprotein-receptor gene causing familial hypercholesterolemia in the Japanese population. Arterioscler Thromb Vasc Biol, 15: 1713−1718, 1995","DOI":"10.1161\/01.ATV.15.10.1713"},{"key":"4","doi-asserted-by":"crossref","unstructured":"(4) Yu W, Nohara A, Higashikata T, Lu H, Inazu A, and Mabuchi H: Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population. Atherosclerosis, 165: 335−342, 2002","DOI":"10.1016\/S0021-9150(02)00249-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"(5) Funahashi T, Yamashita S, Maruyama T, Ueyama Y, Menju M, Nagai Y, Takemura K, Miyake Y, Tajima S and Matsuzawa Y: A compound heterozygote for familial hypercholesterolemia with a homozygous mother. J Intern Med, 239: 187−190, 1996","DOI":"10.1046\/j.1365-2796.1996.406000.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"(6) Soutar AK, Knight BL, and Patel DD: Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors. Proc Natl Acad Sci U S A, 86: 4166−4170, 1989","DOI":"10.1073\/pnas.86.11.4166"},{"key":"7","unstructured":"(7) Kane JP and Havel RJ: Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: The metabolic and molecular bases of inherited disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2717−2752, McGraw-Hill, New York, 2001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"(8) Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, and McCarthy BJ: Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 86: 587−591, 1989","DOI":"10.1073\/pnas.86.2.587"},{"key":"9","doi-asserted-by":"crossref","unstructured":"(9) Gaffney D, Reid JM, Cameron IM, Vass K, Caslake MJ, Shepherd J and Packard CJ: Independent mutations at codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol, 15: 1025−1029, 1995","DOI":"10.1161\/01.ATV.15.8.1025"},{"key":"10","doi-asserted-by":"crossref","unstructured":"(10) Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN and Kane JP: Familial ligand-defective apolipoprotein B: identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest, 95: 1225−1234, 1995","DOI":"10.1172\/JCI117772"},{"key":"11","doi-asserted-by":"crossref","unstructured":"(11) Nohara A, Yagi K, Inazu A, Kajinami K, Koizumi J, and Mabuchi H: Absence of familial defective apolipoprotein B-100 in Japanese patients with familial hypercholesterolemia. Lancet, 345: 1438, 1995","DOI":"10.1016\/S0140-6736(95)92627-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"(12) Harada-Shiba M, Takagi A, Miyamoto Y, Tsushima M, Ikeda Y, Yokoyama S, and Yamamoto A: Clinical features and genetic analysis of autosomal recessive hypercholesterolemia. J Clin Endocrinol Metab, 88: 2541−2547, 2003","DOI":"10.1210\/jc.2002-021487"},{"key":"13","unstructured":"(13) Tarui S: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare of Japan), 1988, pp 11−37 (in Japanese)"},{"key":"14","doi-asserted-by":"crossref","unstructured":"(14) Ohashi K, Ishibashi S, Yamamoto M, Osuga J, Yazaki Y, Yukawa S, and Yamada N: A truncated species of apolipoprotein B (B-38.7) in a patient with homozygous hypobetalipoproteinemia associated with diabetes mellitus. Arterioscler Thromb Vasc Biol, 18: 133−1334, 1998","DOI":"10.1161\/01.ATV.18.8.1330"},{"key":"15","doi-asserted-by":"crossref","unstructured":"(15) Ohashi K, Ishibashi S, Osuga J, Tozawa R, Harada K, Yahagi N, Shionoiri F, Iizuka Y, Tamura Y, Nagai R, Illingworth DR, Gotoda T, and Yamada N: Novel mutations in the microsomal triglyceride transfer protein gene causing abetalipoproteinemia. J Lipid Res, 41: 1199−1204, 2000","DOI":"10.1016\/S0022-2275(20)33426-X"},{"key":"16","unstructured":"(16) Brunzell JD and Deeb SS: Familial lipoprotein lipase deficiency, apo C-II deficiency, and hepatic lipase deficiency. In: The metabolic and molecular bases of inherited disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2789−2816, McGraw-Hill, New York, 2001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"(17) Kobayashi J, Nishida T, Ameis D, Stahnke G, Schotz MC, Hashimoto H, Fukamachi I, Shirai K, Saito Y, and Yoshida S: A heterozygous mutation (the codon for Ser447 → a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun, 182: 70−77, 1992","DOI":"10.1016\/S0006-291X(05)80113-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"(18) Takagi A, Ikeda Y, Tsutsumi Z, Shoji T, and Yamamoto A: Molecular studies on primary lipoprotein lipase (LPL) deficiency: one base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript. J Clin Invest, 89: 581−591, 1992","DOI":"10.1172\/JCI115624"},{"key":"19","unstructured":"(19) Ikeda Y, Ashida Y, Takagi A, Fukuoka T, Tsuru A, Tsushima M, and Yamamoto A: Mechanism of the production of small dense LDL (sLDL) in hypertriglyceridemia. In: Atherosclerosis XI, ed by Jacotot B, Mathe D, and Fruchart JC, pp 777−788, Elsevier Science, Singapore, 1998"},{"key":"20","unstructured":"(20) Mahley RW and Rall SC: Type III hyperlipoproteinemia (dysbetalipoproteinemia). In: The Metabolic and Molecular Bases of Inherited Disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2835−2862, McGraw-Hill, New York, 2001"},{"key":"21","doi-asserted-by":"crossref","unstructured":"(21) Tajima S, Yamamura T, and Yamamoto A: Analysis of apolipoprotein E5 gene from a patient with hyperlipoproteinemia. J Biochem (Tokyo), 104: 48−52, 1988","DOI":"10.1093\/oxfordjournals.jbchem.a122420"},{"key":"22","doi-asserted-by":"crossref","unstructured":"(22) Tajima S, Yamamura T, Menju M, and Yamamoto A: Analysis of apolipoprotein E7 (apolipoprotein E-Suita) gene from a patient with hyperlipo-proteinemia. J Biochem (Tokyo), 105: 249−253, 1989","DOI":"10.1093\/oxfordjournals.jbchem.a122648"},{"key":"23","doi-asserted-by":"crossref","unstructured":"(23) Oikawa S, Matsunaga A, Saito Y, Sato H, Seki T, Hoshi K, Hayasaka K, Kotake H, Midorikawa H, Sekikawa A, Hara S, Abe K, Toyota T, Jingami H, Nakamura H, and Sasaki J: Apolipoprotein E Sendai (arginine 145 proline): a new variant associated with lipoprotein glomerulopathy. J Am Soc Nephrol, 8: 820−823, 1997","DOI":"10.1681\/ASN.V85820"},{"key":"24","doi-asserted-by":"crossref","unstructured":"(24) Saito T, Ishigaki Y, Oikawa S, and Yamamoto T: Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy. Trends Cardiovasc Med, 12: 67−70, 2002","DOI":"10.1016\/S1050-1738(01)00148-7"},{"key":"25","doi-asserted-by":"crossref","unstructured":"(25) Maruyama T, Sakai N, Ishigami M, Hirano K, Arai T, Okada S, Okuda E, Ohya A, Nakajima N, Kadowaki K, Fushimi E, Yamashita S, and Matsuzawa Y: Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia. Atherosclerosis, 166: 177−185, 2003","DOI":"10.1016\/S0021-9150(02)00327-1"},{"key":"26","unstructured":"(26) Tall AR, Breslow JL, and Rubin EM: Genetic disorders affecting plasma high-density lipoproteins. In: The Metabolic and Molecular Bases of Inherited Disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2915−2936, McGraw-Hill, New York, 2001"},{"key":"27","doi-asserted-by":"crossref","unstructured":"(27) Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, and Tall AR: Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipolroteins. Nature, 342: 448−451, 1989","DOI":"10.1038\/342448a0"},{"key":"28","doi-asserted-by":"crossref","unstructured":"(28) Takahashi K, Jiang XC, Sakai N, Yamashita S, Hirano K, Bujo H, Yamazaki H, Kusunoki J, Miura T, Kussie P, Matsuzawa Y, Saito Y, and Tall A: A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins. J Clin Invest, 92: 2060−2064, 1993","DOI":"10.1172\/JCI116802"},{"key":"29","unstructured":"(29) Santamarina-Fojo S, Hoeg JM, and Assmann G: Lecithin:cholesterol acyltransferase deficiency and fish eye disease. In: The Metabolic and Molecular Bases of Inherited Disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2817−2833, McGraw-Hill, New York, 2001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"(30) Maeda E, Naka Y, Matozaki T, Sakuma M, Akanuma Y, Yoshino G, and Kasuga M: Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT gene. Biochem Biophys Res Commun, 178: 460−466, 1991","DOI":"10.1016\/0006-291X(91)90129-U"},{"key":"31","unstructured":"(31) Deeb SS, Takata K, Peng R, Kajiyama G, and Albers JJ: A splice-junction mutation responsible for familial apolipoprotein A-II deficiency. Am J Hum Genet, 46: 822−827, 1990"},{"key":"32","unstructured":"(32) Assmann G, von Eckardstein A, and Brewer HB Jr: Familial analphalipoproteinemia: Tangier disease. In: The Metabolic and Molecular Bases of Inherited Disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2937−2960, McGraw-Hill, New York, 2001"},{"key":"33","unstructured":"(33) Bjorkhem I, Boberg KM, and Leitersdorf E: Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: The Metabolic and Molecular Bases of Inherited Disease. 8th Ed, ed by Scriver CR, Beaudet AL, Sly WS, and Valle D, pp 2961−2988, McGraw-Hill, New York, 2001"},{"key":"34","doi-asserted-by":"crossref","unstructured":"(34) Lee MH, Lu K, Hazard S, Yu H, Shulenin S, Hidaka H, Kojima H, Allikmets R, Sakuma N, Pegoraro R, Srivastava AK, Salen G, Dean M, and Patel SB: Identification of a gene, ABCG5, important in the regulation of dietary cholesterol absorption. Nat Genet, 27: 79−83, 2001","DOI":"10.1038\/83799"},{"key":"35","unstructured":"(35) Yamashita S: Clinical characteristics and mutational analysis in Japanese patients with primary hyperlipidemia. In: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare of Japan), pp 43−50, 1996 (in Japanese)"},{"key":"36","unstructured":"(36) Bujo H: Clinical characteristics and mutational analysis in Japanese patients with primary hyperlipidemia. In: Annual report of research committee on primary hyperlipidemia (Ministry of Health and Welfare of Japan), pp 50−58, 1997 (in Japanese)"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/3\/11_3_131\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T09:55:29Z","timestamp":1637834129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/11\/3\/11_3_131\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.11.131","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004]]}}}